Page last updated: 2024-08-21

quinazolines and Depression, Endogenous

quinazolines has been researched along with Depression, Endogenous in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Cui, YL; Qiao, T; Qiu, C; Wang, Y; Xu, D1
Auld, DS; Cole, AG; Desai, H; Goan, KA; Ho, KK; Letourneau, JJ; Li, H; Morphy, JR; Napier, SE; Ohlmeyer, MH; Riviello, CM; Thomson, FJ; Webb, ML; Zanetakos, HA; Zhao, J1

Other Studies

2 other study(ies) available for quinazolines and Depression, Endogenous

ArticleYear
Intranasal co-delivery of berberine and evodiamine by self-assembled thermosensitive in-situ hydrogels for improving depressive disorder.
    International journal of pharmaceutics, 2021, Jun-15, Volume: 603

    Topics: Administration, Intranasal; Animals; Berberine; Depressive Disorder; Hydrogels; Mice; Quinazolines; Rats; Temperature

2021
Identification and optimization of novel 2-(4-oxo-2-aryl-quinazolin-3(4H)-yl)acetamide vasopressin V3 (V1b) receptor antagonists.
    Bioorganic & medicinal chemistry letters, 2010, Sep-15, Volume: 20, Issue:18

    Topics: Acetamides; Animals; Antidiuretic Hormone Receptor Antagonists; Depressive Disorder; Humans; Quinazolines; Rats; Receptors, Vasopressin; Structure-Activity Relationship

2010